Gallant Pet, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Gallant Pet, Inc. - overview

Established

2018

Location

San Diego, CA-California, US

Primary Industry

Biotechnology

About

Founded in 2018 and based in California, US, Gallant Pet, Inc. , trading under the name Gallant Therapeutics, is a company that provides healthcare solutions using stem cell therapy for dogs and cats. In June 2025, Gallant Pet, Inc. raised USD 18 million in series B funding led by returning investor Digitalis Ventures, with participation from other returning investors BOLD Capital Partners and Hill Creek Partners.


New investor NovaQuest Capital Management also participated in the round. Gallant's offerings includes an off-the-shelf stem cell platform that helps in mitigating symptoms and treating the causes of pet diseases. The firm helps its customers with stem cell collection, stem cell banking, and regenerative treatments for pets. The company will use the June 2025 funding for product development.


Current Investors

Maveron, BOLD Capital Partners, Science

Primary Industry

Biotechnology

Sub Industries

Pet Products, Biopharmaceuticals

Website

www.gallant.com

Verticals

HealthTech

Company Stage

Series B

Total Amount Raised

Subscriber access only

Gallant Pet, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Series BCompletedGallant Pet, Inc.-
Series ACompletedGallant Pet, Inc.-
Series ACompletedGallant Pet, Inc.-
Unspecified RoundCompletedGallant Pet, Inc.-
Unspecified RoundCompletedGallant Pet, Inc.-

Displaying 1 - 5 of 5

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.